Last reviewed · How we verify
NCT03738644
Monitoring Stroke Patients With Near-infrared Spectroscopy Before, During and After Endovascular Treatment
trial testing Monitoring with near-infrared spectroscopy in Ischemic Stroke in 100 participants. Completed in 15 February 2021.
15 February 2021
Quick facts
| Lead sponsor | Helle Klingenberg Iversen |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 100 |
| Start date | 20 November 2018 |
| Primary completion | 15 February 2021 |
| Estimated completion | 15 February 2021 |
| Sites | 1 location across Denmark |
Drugs / interventions tested
- Monitoring with near-infrared spectroscopy
Conditions studied
- Ischemic Stroke — all drugs for Ischemic Stroke →
Sponsor
Helle Klingenberg Iversen
Who can join
18 and older, any sex, with Ischemic Stroke. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to examine the hemodynamics of stroke patients with near-infrared spectroscopy before, during and after endovascular treatment and their relations to disabilities and mortality 3 months after treatment.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Bilateral dynamic cerebral autoregulation assessment during endovascular treatment in large-vessel occlusion stroke.
Heiberg AV, Lukassen TG, Truelsen TC, Borgwardt HG, et al · · 2026 · cited 1× · PMID 41264560 · DOI 10.1113/ep093024 -
Dynamic cerebral autoregulation during and 3 months after endovascular treatment in large vessel occlusion stroke.
Heiberg AV, Lukassen TG, Truelsen TC, Borgwardt HG, et al · · 2025 · cited 1× · PMID 40830559 · DOI 10.1038/s41598-025-14672-y -
Dynamic cerebral autoregulation during and 3 months after endovascular treatment in large vessel occlusion stroke
Heiberg AV, Lukassen TG, Truelsen TC, Borgwardt HG, et al · · 2024 · DOI 10.1101/2024.09.05.24313166
Verify or expand the search:
- PubMed search for NCT03738644
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Ischemic Stroke
Currently open trials in the same condition.
- NCT07509645 — Efficacy and Safety of Interleukin-6 Receptor Inhibitor Combined With Endovascular Treatment in Patients With Acute Post · Phase 3 · recruiting
- NCT07375953 — Repeated Intravenous Thrombolysis for Ischemic Stroke Within 3.0 Hours of Onset With Tenecteplase (RITIS-TNK) · Phase 2 · recruiting
- NCT07375966 — Repeated Intravenous Thrombolysis for Ischemic Stroke With Medium to Large Vessel Occlusion Presenting Within 4.5 Hours · Phase 2 · recruiting
- NCT07491952 — Continuous Dual Aspiration Technique With Zoom System for Stroke · recruiting
- NCT07371455 — A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LWP779 in Healthy Participants · Phase 1 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03738644 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Helle Klingenberg Iversen
- Last refreshed: 18 March 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03738644.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing